Bizarre Patents
Pizza Pie With Concentric Rings of Crust
A pizza mold for forming a plurality of concentric raised ridges of dough (i.e., crust) on the surface of a pizza pie.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8175843 | Computer-implemented methods for evaluating, summarizing and presenting data on stability of drug substances and drug products and software-modified computers for such methods Computer-implemented methods for statistical analysis and summarization of a stability study on a pharmaceutical product using of a macro integrated into statistical analysis software. The method includes inputting and summarizing data observed for a stability study... | 05/08/2012 |
| 8163911 | Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions The invention relates to substituted arylsulphonylaminomethylphosphonic acid derivatives of general formula (I) wherein the groups Ra to Rf, A and Z are defined as mentioned in the specification and claims, which are suitable for preparing a me... | 04/24/2012 |
| 8067590 | Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds The present invention relates to compounds of general formula I wherein the groups and radicals B, k, L, U, V, W, X, Y, Z, R1, R2, have the meanings given in claim 1. Moreover the invention rela... | 11/29/2011 |
| 8062626 | Stable pharmaceutical budesonide preparation for producing propellant-free aerosols The invention relates to ethanol-containing pharmaceutical preparations for the production of propellant-free aerosols. ... | 11/22/2011 |
| 7981880 | 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors The present invention encompasses compounds of general formula (1) wherein R1, R2, R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and th... | 07/19/2011 |
| 7981827 | Chiral phosphanes for use in asymmetric syntheses The present invention relates to biarylbisphosphines and intermediates thereof. Furthermore, the scope of the invention encompasses catalysts which can be prepared from the bisarylphosphines and their use in asymmetric syntheses. ... | 07/19/2011 |
| 7980243 | Two-chamber cartridge for propellant-free metering aerosols A cartridge for propellant-free administration of a liquid pharmaceutical composition by inhalation includes: an elongate displacing device including an upper end and a lower end, the lower end for at least partial insertion into a container; a cartridge chamber dis... | 07/19/2011 |
| 7963955 | Container for a medicinal liquid Foil bags are used as a primary packaging for liquids, the bags permitting the liquid to be taken therefrom without the application of a considerable amount of force. A container is provided for a medicinal liquid, the container being gas-tight and liquid-tight so t... | 06/21/2011 |
| 7919312 | Self-replicating RNA molecule from hepatitis C virus A unique HCV RNA molecule is provided having an enhanced efficiency of establishing cell culture replication. Novel adaptive mutations have been identified within the HCV non-structural region that improves the efficiency of establishing persistently replicating HCV... | 04/05/2011 |
| 7829664 | Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof An isolated chimeric GLP-1 nucleic acid sequence encoding a human pro-insulin leader, a glucagon-like peptide-1 (GLP-1), and a furin cleavable site between the human pro-insulin leader sequence and the GLP-1 is provided. Also provided is an isolated modified chimeri... | 11/09/2010 |
| 7820815 | Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines The invention relates to an improved process for preparing enantiomerically pure 8-(3-aminopiperidin-1-yl)-xanthines. The process involves reacting a compound of the formula (III) with 3-(phthalimido)piperidine or an enantiomer thereof | 10/26/2010 |
| 7819342 | Atomizer for dispensing liquids for medical purposes Atomizers (1) comprising a cartridge holder (4) which is arranged in the housing (3), a mouthpiece (5) which is provided on the housing (3) and in which an atomization device (6) is arranged, and a connecting tube system ( | 10/26/2010 |
| RE41894 | Hepatitis C inhibitor tri-peptides Racemates, diastereoisomers and optical isomers of a compound of formula (I): wherein B is H, a C6 or C10 aryl, C7-16 aralkyl; Het or (lower alkyl)-Het, all of w... | 10/26/2010 |
| 7816530 | Piperazinyl compounds Disclosed are new dihydropteridinones of general formula (I) wherein the groups L and R1-R5 have the meanings given in the claims and specification, the isomers thereof, intermediates and processes for... | 10/19/2010 |
| 7816348 | Viral polymerase inhibitors Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase. ... | 10/19/2010 |
| 7807864 | Transgenic animal as a model for fibrotic diseases Disclosed is a transgenic non-human animal with broad or cell type-specific ectopic expression of fra-2 that manifests itself in a fibrotic disease, methods for obtaining such animal and their use. Fra-2 transgenic animals, in particular mice, are useful as model sy... | 10/05/2010 |
| 7807831 | Dihydropteridione derivatives, process for their manufacture and their use as medicament Disclosed are new dihydropteridinones of the formula (I) wherein the groups L, R1, R2, R3, R4 and R5 have the meanings provided herein, the isomers thereof, processes f... | 10/05/2010 |
| 7807670 | Inhibitors of papilloma virus A compound of formula (I) or its enantiomers or diastereoisomers thereof: wherein: A,; X, W, R1, Y; R3; and R4 are as defined herein. The compounds of the invention may be used as in... | 10/05/2010 |
| 7807666 | CGRP antagonists The invention relates to a method for treating irritable bowel syndrome through the use of effective amounts of a compound acting as CGRP antagonist. ... | 10/05/2010 |
| 7803944 | Viral polymerase inhibitors An isomer, enantiomer, diastereoisomer, or tautomer of a compound, represented by formula I: wherein: A is O, S, NR1, or CR1, wherein R1 is defined herein; — repr... | 09/28/2010 |
| 7802568 | Cartridge for a liquid For meteredly dispensing a liquid over a period of several months from a container which can be stored over a long period of time, the need is for a container which is practically diffusion-tight and in which the liquid does not come into contact with the ambient at... | 09/28/2010 |
| 7799562 | Hybridoma producing antibodies to lawsonia intracellularis The present invention relates to the field of animal health and in particular to Lawsonia intracellularis. In particular, the invention relates to a method of diagnosing Lawsonia intracellularis infection and a diagnostic test kit using Lawsonia int... | 09/21/2010 |
| 7794735 | Pathogen for bacterial poultry disease The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, Gallibacterium. The invention provides said Gallibacterium bacteria, vaccine comprising inactivated Gallibacterium, and... | 09/14/2010 |
| 7793655 | Two-chamber cartridge for propellant-free metering aerosols A cartridge for propellant-free administration of a liquid pharmaceutical composition by inhalation includes: an elongate displacing device including an upper end and a lower end, the lower end for at least partial insertion into a container; a cartridge chamber dis... | 09/14/2010 |
| 7790712 | Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors The application relates to compounds of formula Ia and analogues thereof wherein R1 to R13 and X are as defined herein. The invention also relates to the use of the compounds of formula Ia as inhibitor... | 09/07/2010 |
| 7786299 | Methods for treating diseases or conditions using dihydropteridinone compounds Disclosed are new dihydropteridinones of general formula (I) wherein the groups L and R1-R5 have the meanings given in the claims and specification, the isomers thereof, intermediates and processes for... | 08/31/2010 |
| 7786111 | Medicaments for the treatment of chronic obstructive pulmonary disease A pharmaceutical composition comprising a compound of formula 1 wherein: n is 1 or 2; R1 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4 | 08/31/2010 |
| 7776830 | Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture Glucopyranosyl-substituted benzonitrile derivatives defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabo... | 08/17/2010 |
| 7776315 | Pharmaceutical compositions based on anticholinergics and additional active ingredients A pharmaceutical composition comprising an anticholinergic and at least one additional active ingredient selected from among corticosteroids, dopamine agonistes, PDE-IV inhibitors, NK1-antagonists, endothelin antagonists, antihistamines, and EGFR-kinase inhibitors, ... | 08/17/2010 |
| 7767818 | Hepatitis C inhibitor dipeptide analogs Compounds of formula (I): wherein R1, R2, R3, R4, n and m are as defined herein. The compounds are useful as inhibitors of HCV NS3 protease. ... | 08/03/2010 |
| 7763280 | Tiotropium containing powder formulation for inhalation The invention relates to powdered preparations containing tiotropium for inhalation, processes for preparing them as well as their use in preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chro... | 07/27/2010 |
| 7759485 | Process for the manufacture of dihydropteridinones Disclosed are processes for preparing dihydropteridinones of general formula (I) wherein the groups L and R1-R5 have the meanings given in the claims and in the specification. ... | 07/20/2010 |
| 7759365 | Piperidine-substituted indoles Disclosed are novel piperidine-substituted indoles- or heteroderivatives thereof of the formula 1: wherein R1, R5, R6, R7, A, B, D-E, Y, i, j, n and m are defined as below. | 07/20/2010 |
| 7759347 | 2-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments The present invention relates to new 2-benzylaminodihydropteridinones of general formula (I) wherein the groups R1 to R7, R10 and R11 have the meanings given in the claims and spe... | 07/20/2010 |
| 7758936 | Pharmaceutical blister The present invention relates to a new pharmaceutical blister with reduced permeability to water vapor and gas. It is proposed according to the invention to coat conventional blisters with a silicon oxide-containing functional layer to protect against gases, water v... | 07/20/2010 |
| 7754756 | Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, di... | 07/13/2010 |
| 7754481 | Keratinocytes useful for the treatment of wounds The invention relates to new keratinocytes which may be cultured in vitro and the advantageous use thereof for preparing a product which can be used to treat acute and chronic wounds. ... | 07/13/2010 |
| 7750152 | Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same Disclosed are dihydropteridinones of general formula (I) wherein the groups L and R1-R5 have the meanings given in the claims and specification, the pharmaceutical compositions, isomers, intermediates ... | 07/06/2010 |
| 7750009 | Substituted pteridines for the treatment of inflammatory diseases The invention relates to new pteridines which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases o... | 07/06/2010 |
| 7749961 | Macrocyclic peptides active against the hepatitis C virus Compounds of formula (I): wherein R1, R2, X, R3, D, and the dotted line b are as defined herein; or a pharmaceutically acceptable salt or ester thereof, are useful as inhibitors of the HCV N... | 07/06/2010 |
